These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 21739499

  • 21. Vaginal progesterone for prevention of preterm labor in asymptomatic twin pregnancies with sonographic short cervix: a randomized clinical trial of efficacy and safety.
    El-Refaie W, Abdelhafez MS, Badawy A.
    Arch Gynecol Obstet; 2016 Jan; 293(1):61-67. PubMed ID: 26044148
    [Abstract] [Full Text] [Related]

  • 22. Cervical Pessary and Vaginal Progesterone in Twin Pregnancies With a Short Cervix.
    Fox NS, Gupta S, Lam-Rachlin J, Rebarber A, Klauser CK, Saltzman DH.
    Obstet Gynecol; 2016 Apr; 127(4):625-630. PubMed ID: 26959202
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Vaginal progesterone in women with twin gestations complicated by short cervix: a retrospective cohort study.
    Brubaker SG, Pessel C, Zork N, Gyamfi-Bannerman C, Ananth CV.
    BJOG; 2015 Apr; 122(5):712-8. PubMed ID: 25428801
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study.
    Romero R, Nicolaides KH, Conde-Agudelo A, O'Brien JM, Cetingoz E, Da Fonseca E, Creasy GW, Hassan SS.
    Ultrasound Obstet Gynecol; 2016 Sep; 48(3):308-17. PubMed ID: 27444208
    [Abstract] [Full Text] [Related]

  • 29. [The use of progestatives for the prevention of spontaneous preterm birth].
    Azria E.
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1280-1298. PubMed ID: 27776845
    [Abstract] [Full Text] [Related]

  • 30. The prevalence of short cervix between 20 and 24 weeks of gestation and vaginal progesterone for prolonging of gestation.
    Maerdan M, Shi C, Zhang X, Fan L.
    J Matern Fetal Neonatal Med; 2017 Jul; 30(14):1646-1649. PubMed ID: 27600865
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Comparison of short-term outcomes of late pre-term singletons and dichorionic twins and optimal timing of delivery.
    Suzuki S, Inde Y, Miyake H.
    J Obstet Gynaecol; 2010 Jul; 30(6):574-7. PubMed ID: 20701505
    [Abstract] [Full Text] [Related]

  • 33. [First year experience using arabin cervical pessary with intravaginal micronized progesterone for the prevention of preterm birth in patients with mid-trimester short cervix].
    Zimerman AL, Neeman O, Wiener Y, Maymon R, Arie H.
    Harefuah; 2014 Feb; 153(2):79-82, 127. PubMed ID: 24716423
    [Abstract] [Full Text] [Related]

  • 34. Intravaginal use of natural micronised progesterone to prevent pre-term birth: a randomised trial in India.
    Majhi P, Bagga R, Kalra J, Sharma M.
    J Obstet Gynaecol; 2009 Aug; 29(6):493-8. PubMed ID: 19697195
    [Abstract] [Full Text] [Related]

  • 35. Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial.
    Martinez de Tejada B, Karolinski A, Ocampo MC, Laterra C, Hösli I, Fernández D, Surbek D, Huespe M, Drack G, Bunader A, Rouillier S, López de Degani G, Seidenstein E, Prentl E, Antón J, Krähenmann F, Nowacki D, Poncelas M, Nassif JC, Papera R, Tuma C, Espoile R, Tiberio O, Breccia G, Messina A, Peker B, Schinner E, Mol BW, Kanterewicz L, Wainer V, Boulvain M, Othenin-Girard V, Bertolino MV, Irion O, 4P trial group.
    BJOG; 2015 Jan; 122(1):80-91. PubMed ID: 25209926
    [Abstract] [Full Text] [Related]

  • 36. Does progesterone prophylaxis to prevent preterm labour improve outcome? A randomised double-blind placebo-controlled trial (OPPTIMUM).
    Norman JE, Marlow N, Messow CM, Shennan A, Bennett PR, Thornton S, Robson SC, McConnachie A, Petrou S, Sebire NJ, Lavender T, Whyte S, Norrie J.
    Health Technol Assess; 2018 Jun; 22(35):1-304. PubMed ID: 29945711
    [Abstract] [Full Text] [Related]

  • 37. Development of children born to women with twin pregnancies treated with cervical pessary or vaginal progesterone: Follow-up of a randomized controlled trial.
    Tran VTT, Nguyen NA, Nguyen NT, Vo TTM, Uong TS, Nguyen HT, Nguyen NT, Pham TD, Nguyen MHN, Vuong LN, Mol BW, Dang VQ.
    Acta Obstet Gynecol Scand; 2023 May; 102(5):626-634. PubMed ID: 36905390
    [Abstract] [Full Text] [Related]

  • 38. Progesterone does not prevent preterm births in women with twins.
    Briery CM, Veillon EW, Klauser CK, Martin RW, Chauhan SP, Magann EF, Morrison JC.
    South Med J; 2009 Sep; 102(9):900-4. PubMed ID: 19668021
    [Abstract] [Full Text] [Related]

  • 39. Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery.
    Spong CY, Meis PJ, Thom EA, Sibai B, Dombrowski MP, Moawad AH, Hauth JC, Iams JD, Varner MW, Caritis SN, O'Sullivan MJ, Miodovnik M, Leveno KJ, Conway D, Wapner RJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S, National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network.
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1127-31. PubMed ID: 16157124
    [Abstract] [Full Text] [Related]

  • 40. Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial.
    Cetingoz E, Cam C, Sakallı M, Karateke A, Celik C, Sancak A.
    Arch Gynecol Obstet; 2011 Mar; 283(3):423-9. PubMed ID: 20091317
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.